Dr. Reddy's new generic is now available in the US

Dr. Reddy's Laboratories announces the launch of Aripiprazole tablets, USP tablets in the U.S. Market

id-10039602-1

Dr. Reddy's Laboratories announced that it has launched Aripiprazole tablets, USP, in 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, a therapeutic equivalent generic version of Abilify (aripiprazole) tablets in the United States market approved by the U.S. Food & Drug Administration (USFDA).


The Abilify brand and generic tablets had U.S. sales of approximately $3.1 billion MAT for the most recent twelve months ending in August 2016 according to IMS Health.

Dr.Reddy's Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30.

Abilify is a registered trademark of Otsuka Pharmaceutical Company.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X